In the latest episode of Molecule to Market, Jon Alberdi, CEO at VIVEbiotech, shares an honest and insightful conversation about his journey — from the Basque Country to international boardrooms, from the automotive industry to the fast-moving world of lentiviral vectors and advanced therapies.
This is a professional interview with a deeply human touch. Jon reflects on pivotal career moments, the transition into biotech leadership, the value of purpose and passion in management, and how strategic partnerships — such as the one with Ampersand — are shaping our growth. He also dives into the challenges and opportunities of industrializing innovation in the CAR-T space and highlights the collective merit of the VIVEbiotech team in navigating this complex landscape.
Jon’s warmth and transparency shine throughout the episode, making it a truly engaging listen for anyone interested in leadership, biotech, and the future of cell and gene therapy.
Highly recommended listening: https://moleculetomarketpod.com/episodes/the-ceo-driven-by-lentiviral-vector-success/